Metadoxil (Metadoxine)

Metadoxine is thought to boost mitochondrial activity in liver cells, increase glutathione levels, and facilitate the conversion of toxic ammonia into less harmful compounds. These actions protect hepatocytes from oxidative damage and aid in restoring normal liver metabolism.

The dosage of Metadoxil is individualized by the prescribing clinician based on the patient’s clinical status, severity of liver disease, and other medical considerations. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for Metadoxil in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Metadoxil, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metadoxil belongs to the hepatoprotective class and is distinguished by its proposed dual action on mitochondrial function and ammonia detoxification. Compared with other agents such as silymarin or ursodeoxycholic acid, Metadoxil offers a unique metabolic support profile, though clinical choice depends on individual patient factors and physician judgment.

Metadoxil should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Metadoxil is taken orally, typically as a tablet. It should be swallowed with a glass of water, and the exact timing (e.g., with meals or on an empty stomach) should follow the prescribing clinician’s instructions.

Serious risks, though rare, include worsening liver failure, severe allergic reactions such as anaphylaxis, blood dyscrasias like neutropenia, and pancreatitis. Patients should be monitored for any signs of these conditions and seek immediate medical attention if they occur.

Metadoxil is contraindicated in patients with known hypersensitivity to Metadoxine or any excipients in the formulation. Caution is also advised for individuals with severe hepatic impairment, uncontrolled alcohol use, or those taking medications that may cause significant drug‑drug interactions.